BRIEF-Carisma Therapeutics Announces Restructuring

Reuters12-09

Dec 9 (Reuters) - Carisma Therapeutics :

* CARISMA THERAPEUTICS ANNOUNCES STRATEGIC RESTRUCTURING TO RE-PRIORITIZE PIPELINE

* CARISMA THERAPEUTICS INC -DEVELOPMENT OF CT-0525 TO BE DISCONTINUED; WORKFORCE REDUCED BY 34%

* CARISMA THERAPEUTICS INC - EXPECTS $2.7 MILLION COST FOR WORKFORCE REDUCTION

* CARISMA THERAPEUTICS INC - CHIEF FINANCIAL OFFICER, RICHARD MORRIS WILL LEAVE COMPANY EFFECTIVE DEC 31

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490278847?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-09 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490278847","market":"us","top_or_hot":-1,"title":"BRIEF-Carisma Therapeutics Announces Restructuring","media":"Reuters","content":"<html><body><p>Dec 9 (Reuters) - <a href=\"https://laohu8.com/S/CARM\">Carisma Therapeutics</a>   :</p><p>   * CARISMA THERAPEUTICS ANNOUNCES STRATEGIC RESTRUCTURING TO RE-PRIORITIZE PIPELINE</p><p>   * CARISMA THERAPEUTICS INC -DEVELOPMENT OF CT-0525 TO BE DISCONTINUED; WORKFORCE REDUCED BY 34%</p><p>   * CARISMA THERAPEUTICS INC - EXPECTS $2.7 MILLION COST FOR WORKFORCE REDUCTION</p><p>   * CARISMA THERAPEUTICS INC - CHIEF FINANCIAL OFFICER, RICHARD MORRIS WILL LEAVE COMPANY EFFECTIVE DEC 31</p><p>Source text:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Carisma Therapeutics Announces Restructuring</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Carisma Therapeutics Announces Restructuring\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-09 21:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 9 (Reuters) - Carisma Therapeutics   :   * CARISMA THERAPEUTICS ANNOUNCES STRATEGIC RESTRUCTURING TO RE-PRIORITIZE PIPELINE   * CARISMA THERAPEUTICS INC -DEVELOPMENT OF CT-0525 TO BE DISCONTINUED;...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CARM","symbol_name":"Carisma Therapeutics","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2490278847","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490278847","pubTimestamp":1733751321,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Dec 9  - Carisma Therapeutics   :   * CARISMA THERAPEUTICS ANNOUNCES STRATEGIC RESTRUCTURING TO RE-PRIORITIZE PIPELINE   * CARISMA THERAPEUTICS INC -DEVELOPMENT OF CT-0525 TO BE DISCONTINUED; WORKFORCE REDUCED BY 34%   * CARISMA THERAPEUTICS INC - EXPECTS $2.7 MILLION COST FOR WORKFORCE REDUCTION   * CARISMA THERAPEUTICS INC - CHIEF FINANCIAL OFFICER, RICHARD MORRIS WILL LEAVE COMPANY EFFECTIVE DEC 31Source text:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CARM":"Carisma Therapeutics","BK4139":"生物科技"},"translate_title":"简介-Carisma Therapeutics宣布重组","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CARM":1},"content_text":"Dec 9 (Reuters) - Carisma Therapeutics   :   * CARISMA THERAPEUTICS ANNOUNCES STRATEGIC RESTRUCTURING TO RE-PRIORITIZE PIPELINE   * CARISMA THERAPEUTICS INC -DEVELOPMENT OF CT-0525 TO BE DISCONTINUED; WORKFORCE REDUCED BY 34%   * CARISMA THERAPEUTICS INC - EXPECTS $2.7 MILLION COST FOR WORKFORCE REDUCTION   * CARISMA THERAPEUTICS INC - CHIEF FINANCIAL OFFICER, RICHARD MORRIS WILL LEAVE COMPANY EFFECTIVE DEC 31Source text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490278847"}